Cargando…
A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
BACKGROUND: Tumor metastasis is one of the main causes of the high mortality of hepatocellular carcinoma (HCC). E-Twenty Six variant gene 6 (ETV6) is a strong transcriptional repressor, associated with the development and progression of tumors. However, the exact role and underlying mechanism of ETV...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178969/ https://www.ncbi.nlm.nih.gov/pubmed/32326970 http://dx.doi.org/10.1186/s13046-020-01559-1 |
_version_ | 1783525574868729856 |
---|---|
author | Guo, Chunmei Gao, Chao Zhao, Dongting Li, Jiahui Wang, Jinxia Sun, Xujuan Liu, Qinlong Hao, Lihong Greenaway, Frederick T. Tian, Yuxiang Liu, Shuqing Sun, Ming-Zhong |
author_facet | Guo, Chunmei Gao, Chao Zhao, Dongting Li, Jiahui Wang, Jinxia Sun, Xujuan Liu, Qinlong Hao, Lihong Greenaway, Frederick T. Tian, Yuxiang Liu, Shuqing Sun, Ming-Zhong |
author_sort | Guo, Chunmei |
collection | PubMed |
description | BACKGROUND: Tumor metastasis is one of the main causes of the high mortality of hepatocellular carcinoma (HCC). E-Twenty Six variant gene 6 (ETV6) is a strong transcriptional repressor, associated with the development and progression of tumors. However, the exact role and underlying mechanism of ETV6 in HCC remain unclear. METHODS: Western blotting, quantitative real-time PCR and immunohistochemistry were used to detect the expression levels of ETV6, CRKL (v-crk sarcoma virus CT10 oncogene homologue (avian)-like) and miR-429 in HCC tissues and cells; Transwell chamber and F-actin cytoskeleton staining assay to examine the effects of ETV6 and CRKL deregulation on the migration, invasion and cytoskeleton of HCC cells; Co-immunoprecipitation assay to determine the interaction between CRKL and ETV6; Chromatin immunoprecipitation assay to investigate the interaction between ETV6 and miR-429. RESULTS: We established a novel ETV6-miR-429-CRKL regulatory circuitry contributes to HCC metastasis. ETV6 and CRKL were frequently increased, while miR-429 was downregulated in both hepatocarcinoma tissues and hepatocarcinoma cells. Moreover, ETV6 upregulation was positively correlated with CRKL upregulation, and two negative correlations were also established for ETV6 and CRKL upregulation with miR-429 downregulation in both hepatocarcinoma patients’ tumorous tissues and hepatocarcinoma cells. Functional investigations revealed that overexpression and knockdown of ETV6 was remarkably effective in promoting and suppressing HCC cell migration, invasion, cytoskeleton F-actin expression and arrangement, whereas, CRKL overexpression exhibited similar effects to the overexpression of ETV6. Mechanistically, ETV6 negatively regulates miR-429 expression by directly binding to the promoter region of miR-429; miR-429 negatively regulates CRKL expression by selectively targeting CRKL-3′-UTR; ETV6 directly binds to CRKL and positively regulates its expression, which in turn CRKL positively regulates ETV6 expression. CONCLUSIONS: Our data demonstrated that ETV6 promotes migration and invasion of HCC cells by directly binding to promoter region of miR-429 via modulating CRKL expression. The newly identified ETV6-miR-429-CRKL regulatory circuitry contributes to the aggressiveness of HCC, which provides new clues for fundamental research on diagnosis and treatment parameters for HCC. |
format | Online Article Text |
id | pubmed-7178969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71789692020-04-26 A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma Guo, Chunmei Gao, Chao Zhao, Dongting Li, Jiahui Wang, Jinxia Sun, Xujuan Liu, Qinlong Hao, Lihong Greenaway, Frederick T. Tian, Yuxiang Liu, Shuqing Sun, Ming-Zhong J Exp Clin Cancer Res Research BACKGROUND: Tumor metastasis is one of the main causes of the high mortality of hepatocellular carcinoma (HCC). E-Twenty Six variant gene 6 (ETV6) is a strong transcriptional repressor, associated with the development and progression of tumors. However, the exact role and underlying mechanism of ETV6 in HCC remain unclear. METHODS: Western blotting, quantitative real-time PCR and immunohistochemistry were used to detect the expression levels of ETV6, CRKL (v-crk sarcoma virus CT10 oncogene homologue (avian)-like) and miR-429 in HCC tissues and cells; Transwell chamber and F-actin cytoskeleton staining assay to examine the effects of ETV6 and CRKL deregulation on the migration, invasion and cytoskeleton of HCC cells; Co-immunoprecipitation assay to determine the interaction between CRKL and ETV6; Chromatin immunoprecipitation assay to investigate the interaction between ETV6 and miR-429. RESULTS: We established a novel ETV6-miR-429-CRKL regulatory circuitry contributes to HCC metastasis. ETV6 and CRKL were frequently increased, while miR-429 was downregulated in both hepatocarcinoma tissues and hepatocarcinoma cells. Moreover, ETV6 upregulation was positively correlated with CRKL upregulation, and two negative correlations were also established for ETV6 and CRKL upregulation with miR-429 downregulation in both hepatocarcinoma patients’ tumorous tissues and hepatocarcinoma cells. Functional investigations revealed that overexpression and knockdown of ETV6 was remarkably effective in promoting and suppressing HCC cell migration, invasion, cytoskeleton F-actin expression and arrangement, whereas, CRKL overexpression exhibited similar effects to the overexpression of ETV6. Mechanistically, ETV6 negatively regulates miR-429 expression by directly binding to the promoter region of miR-429; miR-429 negatively regulates CRKL expression by selectively targeting CRKL-3′-UTR; ETV6 directly binds to CRKL and positively regulates its expression, which in turn CRKL positively regulates ETV6 expression. CONCLUSIONS: Our data demonstrated that ETV6 promotes migration and invasion of HCC cells by directly binding to promoter region of miR-429 via modulating CRKL expression. The newly identified ETV6-miR-429-CRKL regulatory circuitry contributes to the aggressiveness of HCC, which provides new clues for fundamental research on diagnosis and treatment parameters for HCC. BioMed Central 2020-04-23 /pmc/articles/PMC7178969/ /pubmed/32326970 http://dx.doi.org/10.1186/s13046-020-01559-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Guo, Chunmei Gao, Chao Zhao, Dongting Li, Jiahui Wang, Jinxia Sun, Xujuan Liu, Qinlong Hao, Lihong Greenaway, Frederick T. Tian, Yuxiang Liu, Shuqing Sun, Ming-Zhong A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
title | A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
title_full | A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
title_fullStr | A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
title_full_unstemmed | A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
title_short | A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
title_sort | novel etv6-mir-429-crkl regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178969/ https://www.ncbi.nlm.nih.gov/pubmed/32326970 http://dx.doi.org/10.1186/s13046-020-01559-1 |
work_keys_str_mv | AT guochunmei anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT gaochao anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT zhaodongting anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT lijiahui anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT wangjinxia anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT sunxujuan anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT liuqinlong anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT haolihong anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT greenawayfrederickt anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT tianyuxiang anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT liushuqing anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT sunmingzhong anoveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT guochunmei noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT gaochao noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT zhaodongting noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT lijiahui noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT wangjinxia noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT sunxujuan noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT liuqinlong noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT haolihong noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT greenawayfrederickt noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT tianyuxiang noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT liushuqing noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma AT sunmingzhong noveletv6mir429crklregulatorycircuitrycontributestoaggressivenessofhepatocellularcarcinoma |